✦ LIBER ✦
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)
✍ Scribed by C Terret; S Zanetta; H Roché; J.H.M Schellens; M.N Faber; J Wanders; M Ravic; J.P Droz
- Book ID
- 117660010
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 218 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.